|
|
|
|
| LEADER |
04194nma a2201213 u 4500 |
| 001 |
EB002158687 |
| 003 |
EBX01000000000000001296802 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230515 ||| eng |
| 020 |
|
|
|a 9783036570754
|
| 020 |
|
|
|a 9783036570747
|
| 020 |
|
|
|a books978-3-0365-7074-7
|
| 100 |
1 |
|
|a Ciaccio, Marcello
|
| 245 |
0 |
0 |
|a Neurodegenerative Diseases
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
| 300 |
|
|
|a 1 electronic resource (262 p.)
|
| 653 |
|
|
|a genetics
|
| 653 |
|
|
|a neurodegenerative disorders
|
| 653 |
|
|
|a circulating microRNA
|
| 653 |
|
|
|a non-coding RNAs
|
| 653 |
|
|
|a excitotoxicity
|
| 653 |
|
|
|a caspase-3
|
| 653 |
|
|
|a Biochemistry / bicssc
|
| 653 |
|
|
|a mercury
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a menopause
|
| 653 |
|
|
|a relapsing-remitting multiple sclerosis
|
| 653 |
|
|
|a remyelination
|
| 653 |
|
|
|a secondary progressive multiple sclerosis
|
| 653 |
|
|
|a nanomedicine
|
| 653 |
|
|
|a rotenone
|
| 653 |
|
|
|a chicoric acid
|
| 653 |
|
|
|a -SH groups
|
| 653 |
|
|
|a mitochondria
|
| 653 |
|
|
|a epigenetics
|
| 653 |
|
|
|a motor functions
|
| 653 |
|
|
|a multiple sclerosis
|
| 653 |
|
|
|a Rab1
|
| 653 |
|
|
|a mitochondrial membrane potential
|
| 653 |
|
|
|a neuroprotective effect
|
| 653 |
|
|
|a blood-brain barrier
|
| 653 |
|
|
|a secretory pathway
|
| 653 |
|
|
|a biological products
|
| 653 |
|
|
|a fibronectin
|
| 653 |
|
|
|a oligodendrocytes
|
| 653 |
|
|
|a Q-VD-OPh
|
| 653 |
|
|
|a gut
|
| 653 |
|
|
|a cell culture techniques
|
| 653 |
|
|
|a PLGA
|
| 653 |
|
|
|a neurodegeneration
|
| 653 |
|
|
|a Golgi fragmentation
|
| 653 |
|
|
|a neurodegenerative diseases
|
| 653 |
|
|
|a buspirone
|
| 653 |
|
|
|a spleen
|
| 653 |
|
|
|a dopamine-D3-receptor
|
| 653 |
|
|
|a striatum
|
| 653 |
|
|
|a apoptosis
|
| 653 |
|
|
|a neuroinflammation
|
| 653 |
|
|
|a GTPases
|
| 653 |
|
|
|a biomarkers
|
| 653 |
|
|
|a Research & information: general / bicssc
|
| 653 |
|
|
|a Biology, life sciences / bicssc
|
| 653 |
|
|
|a central nervous system
|
| 653 |
|
|
|a spiny projection neurons
|
| 653 |
|
|
|a peripheral immune system
|
| 653 |
|
|
|a mice
|
| 653 |
|
|
|a biomarker
|
| 653 |
|
|
|a IGF-1
|
| 653 |
|
|
|a LRRK2
|
| 653 |
|
|
|a superoxide dismutase
|
| 653 |
|
|
|a NMDAR
|
| 653 |
|
|
|a dopamine
|
| 653 |
|
|
|a estrogen
|
| 653 |
|
|
|a extracellular matrix
|
| 653 |
|
|
|a neurodegenerative disease
|
| 653 |
|
|
|a autophagy
|
| 653 |
|
|
|a oxidative stress
|
| 653 |
|
|
|a glutamate receptor antagonist
|
| 653 |
|
|
|a Alzheimer's disease
|
| 653 |
|
|
|a Parkinson's disease
|
| 653 |
|
|
|a liposomes
|
| 653 |
|
|
|a dendritic spines
|
| 653 |
|
|
|a EAE
|
| 653 |
|
|
|a therapeutic targets
|
| 653 |
|
|
|a proteomic
|
| 653 |
|
|
|a precision medicine
|
| 653 |
|
|
|a 6-hydroxydopamine
|
| 653 |
|
|
|a α-synuclein
|
| 653 |
|
|
|a microbiome
|
| 653 |
|
|
|a long-term depression
|
| 700 |
1 |
|
|a Agnello, Luisa
|
| 700 |
1 |
|
|a Ciaccio, Marcello
|
| 700 |
1 |
|
|a Agnello, Luisa
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-7074-7
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/7009
|7 0
|x Verlag
|3 Volltext
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/98956
|z DOAB: description of the publication
|
| 082 |
0 |
|
|a 000
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 540
|
| 520 |
|
|
|a Neurodegenerative diseases (NDs) are a heterogeneous group of complex diseases characterized by neuronal loss and progressive degeneration of different areas of the nervous system. NDs represent a significant health problem worldwide, with an increasing incidence rate. Although the exact pathogenesis of NDs remains unclear, a complex interaction among genetic, epigenetic, and environmental factors has been proposed. To date, no effective therapeutics have been developed to slow, halt, or prevent any NDs. Thus, information on the molecular mechanisms underlying the pathogenesis of NDs is strongly sought after. This Special Issue collected papers discussing advances in the field of NDs.
|